Skip to content

Yoga for People Suffering from Drug Addiction

Yoga Based Intervention for Opioid Dependence: Efficacy and Potential Mechanisms

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/01/017218
Enrollment
60
Registered
2019-01-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F10-F19- Mental and behavioral disorders due to psychoactive substance use

Interventions

Intervention1: Yoga: one hour generic yoga intervention 5 days a week for 3 months. First 2 weeks of supervised sessions followed by home practice. Control Intervention1: Treadmill walk: 1 hour of bri

Sponsors

Department of Science and Technology SATYAM Scheme
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: They will be recruited from Centre for Addiction Medicine, National Institute of Mental Health And Neurosciences (NIMHANS) from the outpatient department and inpatient department. 3. Diagnosed with Opioid dependence syndrome (prescription and street Opioids) as per ICD-10 4. Patients stabilized by medications for withdrawal symptoms 5. Willingness to provide written informed consent

Exclusion criteria

Exclusion criteria: 1. H/o or current medical illness that may significantly influence CNS function or structure 2. Patients with intractable pain due to other diseases 3. Patients on prescribed opioids for pain of other medical conditions 4. General impaired intellectual functioning (Mini-Mental Status Exam, MMSE below24 ) 5. Contraindication to MRI like metal implants or paramagnetic objects within the body or claustrophobia 6. Past history of head injury 7. Concomitant severe medical conditions 8. Those with co-morbid alcohol/BZD/Cannabis/Multiple substance dependence except nicotine 9. H/o receiving specific Yoga practice for Opioid dependence in the past 10. Pregnancy or post-partum

Design outcomes

Primary

MeasureTime frame
Plasma endorphin levels and Buprenorphine dosage requirementTimepoint: At 0, immediate after 1st yoga session, after 2 weeks and at 3 months

Secondary

MeasureTime frame
Various psychometric tests which assess psychological state, craving, withdrawal symptoms, quality of life, suicidality etc. Biological Assessments Other lab assessments: Complete blood count; liver function (AST, ALT, LDH, bilirubin); fMRI acquisition and analysis: Relapse rate and number of hospitalizations will also be assessed Timepoint: At 0, immediate after 1st yoga session, after 2 weeks and at 3 months

Countries

India

Contacts

Public ContactDr Prateek Varshney

NIMHANS, Bengaluru, India

drbhargav.nimhans@gmail.com8762019348

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 9, 2026